Skip to content
MedsAcross

Medicine

Mycophenolate 500 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Mycophenolate 500 mg tablet is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Mycophenolate
Brand
Sold under the generic name
Strength
500 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 100 tablets, 10 blister pack and 36 more
Manufacturers
Ascend LaboratoriesIndiaConcord BiotechIndiaStrides PharmaIndiaAccord HealthcareIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaProficient RxSandozAdvagen Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L04AA06 Mycophenolate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 July 2008
Identifiers
RxCUI 199058, 200060DailyMed set ID 741e079a-646b-47ec-84ac-8e12574c2aaf, 8015f042-54fb-4a7a-a10b-6219e1a450c8, afb59492-2bb1-4cf1-af4b-a5020b56c124 +19NDC 16729-019, 60687-438, 70518-2767 +19Application ANDA065416, ANDA090456, ANDA208119 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
500 tablet, film coated in 1 bottle, plastic42543-989-07Strides PharmaIndia28 February 2025
100 tablet, film coated in 1 bottle, plastic64380-725-06Strides PharmaIndia6 November 2010
500 tablet, film coated in 1 bottle, plastic64380-725-07Strides PharmaIndia6 November 2010
100 tablet in 1 bottle16729-019-01Accord HealthcareIndia4 May 2009
500 tablet in 1 bottle16729-019-16Accord HealthcareIndia4 May 2009
100 tablet, film coated in 1 bottle67877-225-01Ascend LaboratoriesIndia28 November 2011
500 tablet, film coated in 1 bottle67877-225-05Ascend LaboratoriesIndia28 November 2011
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-225-38Ascend LaboratoriesIndia28 November 2011
3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-225-84Ascend LaboratoriesIndia28 November 2011
100 tablet, film coated in 1 bottle59651-638-01Aurobindo PharmaIndia20 February 2024
500 tablet, film coated in 1 bottle59651-638-05Aurobindo PharmaIndia20 February 2024
100 tablet, film coated in 1 bottle, plastic23155-836-01Avet PharmaceuticalsIndia15 October 2022
500 tablet, film coated in 1 bottle, plastic23155-836-05Avet PharmaceuticalsIndia15 October 2022
100 tablet, film coated in 1 bottle31722-879-01Camber PharmaceuticalsIndia22 October 2024
500 tablet, film coated in 1 bottle31722-879-05Camber PharmaceuticalsIndia22 October 2024
30 tablet in 1 bottle68254-5003-1Concord BiotechIndia21 December 2020
100 tablet in 1 bottle68254-5003-2Concord BiotechIndia21 December 2020
500 tablet in 1 bottle68254-5003-3Concord BiotechIndia21 December 2020
100 tablet in 1 bottle72888-185-01Advagen Pharma1 August 2023
500 tablet in 1 bottle72888-185-05Advagen Pharma1 August 2023
100 tablet in 1 bottle0054-0166-25Hikma Pharmaceuticals29 July 2008
500 tablet in 1 bottle0054-0166-29Hikma Pharmaceuticals29 July 2008
100 tablet, film coated in 1 bottle0781-5175-01Sandoz15 October 2008
500 tablet, film coated in 1 bottle0781-5175-05Sandoz15 October 2008
1000 tablet, film coated in 1 bottle0781-5175-10Sandoz15 October 2008
100 pouch in 1 box / 1 tablet, film coated in 1 pouch70518-2767-1Remedyrepack16 December 2021
100 pouch in 1 box / 1 tablet, film coated in 1 pouch70518-4377-0Remedyrepack30 June 2025
180 tablet, film coated in 1 bottle50090-4275-0A-S Medication Solutions19 April 2019
100 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack60687-438-01American Health Packaging14 June 2019
100 tablet, film coated in 1 bottle73190-010-01AvKARE25 April 2025
500 tablet, film coated in 1 bottle73190-010-50AvKARE25 April 2025
50 blister pack in 1 box / 1 tablet, film coated in 1 blister pack50268-558-15AvPAK15 May 2023
120 tablet in 1 bottle63629-9582-1Bryant Ranch Prepack15 November 2022
10 blister pack in 1 bag / 1 tablet, film coated in 1 blister pack55154-3571-0Cardinal Health6 November 2010
100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-7078-61Major Pharmaceuticals6 November 2010
60 tablet, film coated in 1 bottle, plastic68071-3767-6NuCare Pharmaceuticals13 January 2025
30 tablet, film coated in 1 bottle, plastic82804-033-30Proficient Rx25 October 2023
60 tablet, film coated in 1 bottle, plastic82804-033-60Proficient Rx25 October 2023
90 tablet, film coated in 1 bottle, plastic82804-033-90Proficient Rx25 October 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 3 May 1995Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Mycophenolate 500 mg tablet.

Compare 1

Other strengths and forms of Mycophenolate

Clinical summary

Mycophenolate is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. MedsAcross supplies Mycophenolate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Mycophenolate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Mycophenolate 500 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.